C D Zorrilla
Affiliation: University of Puerto Rico
- The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trialsGaston Djomand
HIV Vaccine Trials Network, Seattle, WA, USA
J Acquir Immune Defic Syndr 48:82-9. 2008....
- Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of MedicineCarmen D Zorrilla
Maternal Infant Studies Center CEMI Spanish Acronym, Obstetrics and Gynecology Department, School of Medicine, University of Puerto Rico, San Juan
P R Health Sci J 26:329-35. 2007..The impact of the effectiveness of these programs in having healthy uninfected infants, prolonging and improving the quality of life of those living with HIV, and providing hope to families affected by this epidemic is incalculable...
- Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infantsCarmen D Zorrilla
Obstetrics and Gynecology Department, UPR School of Medicine, P O Box 365067, San Juan, Puerto Rico
Antimicrob Agents Chemother 51:2208-10. 2007..Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia)...
- Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIVC D Zorrilla
Maternal Infant Studies Center CEMI at the University of Puerto Rico School of Medicine, Obstetrics and Gynecology Department, PO Box 365067, San Juan, PR 00936 5067, USA
Cell Mol Biol (Noisy-le-grand) 49:1187-92. 2003..This is also reflected in the good perinatal outcomes. Non-pregnant women with lower adherence rates might need additional interventions to improve adherence...
- An empowerment intervention for women living with HIV and its adaptation for women with a diagnosis of breast cancerCarmen D Zorrilla
Maternal Infant Studies Center CEMI at the University of Puerto Rico School of Medicine, Obstetrics and Gynecology Department, San Juan
Ethn Dis 15:S5-128-32. 2005..We propose that HIV should be viewed as a chronic condition and compared to other conditions that affect women's lives in similar ways...
- Mother-to-child HIV-1 transmission: state of the art and implications for public policyC D Zorrilla
Obstetrics and Gynecology Department, University of Puerto Rico, Rio Piedras
P R Health Sci J 19:29-34. 2000..Shorter and cheaper interventions are also somewhat effective and are good alternatives to resource poor countries...
- Concerns about HIV and sexually transmitted infection among low-risk and high-risk women, Puerto RicoRosimar Torres
Puerto Rico Comprehensive Center for the Study of HIV Health Disparities, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA
Ethn Dis 18:S2-238-41. 2008..Their attitudes toward an HIV diagnosis varied by site. The groups varied in the perception of risk behaviors, knowledge, and concerns. These findings provide useful information for future risk-reduction interventions with these women...
- Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairmentValerie Wojna
NeuroAIDS Program, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
J Neurovirol 12:356-64. 2006....
- Posttraumatic stress disorder symptoms and adherence among women living with HIVCibel M Hilerio
Carlos Albizu University, San Juan Campus, Puerto Rico
Ethn Dis 15:S5-47-50. 2005..This study intends to examine if traumatic experiences affect the way women living with HIV adhere to their medical treatment...
- Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice dailyC D Zorrilla
University of Puerto Rico School of Medicine, San Juan, Puerto Rico
HIV Med 15:50-6. 2014..Physiological changes during pregnancy can affect pharmacokinetics, potentially altering pharmacological activity. We therefore evaluated the pharmacokinetics of twice-daily (bid) darunavir in HIV-1-infected pregnant women...
- HIV infection in women: perinatal issues and cervical cancer surveillanceCarmen D Zorrilla
University of Puerto Rico School of Medicine, San Juan, Puerto Rico
Top HIV Med 15:1-5. 2007..Zorrilla, MD, at the 9th Annual Ryan White CARE Act Clinical Update in Washington, DC, in August 2006. The original presentation is available as a Webcast at www.iasusa.org...
- Spanish validation of the HIV dementia scale in womenV Wojna
NeuroAIDS SNRP, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico
AIDS Patient Care STDS 21:930-41. 2007..0% negative predictive value). The HDS-Spanish translation offers a useful screening tool with value for the identification of Hispanic women at risk of developing HIV-associated symptomatic neurocognitive disturbances...
- Subgroup analyses of maraviroc in previously treated R5 HIV-1 infectionGerd Fatkenheuer
Universitätsklinik Köln, Cologne, Germany
N Engl J Med 359:1442-55. 2008....
- Maraviroc for previously treated patients with R5 HIV-1 infectionRoy M Gulick
Weill Cornell Medical College, New York, NY 10065, USA
N Engl J Med 359:1429-41. 2008..CC chemokine receptor 5 antagonists are a new class of antiretroviral agents...
- Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survivalArlene D Bardeguez
University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA
J Acquir Immune Defic Syndr 32:170-81. 2003....
- The relationship of pregnancy to human immunodeficiency virus disease progressionHoward Minkoff
Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Downstate, Brooklyn, New York 11219, USA
Am J Obstet Gynecol 189:552-9. 2003..This study was undertaken to determine the effect of pregnancy on progression of human immunodeficiency virus (HIV) disease...
- No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmissionKatherine T Chen
Department of Obstetrics and Gynecology and Epidemiology, Columbia University, New York, NY 10032, USA
Am J Obstet Gynecol 198:399.e1-5. 2008..The purpose of this study was to assess the risk of perinatal HIV-1 transmission in women who are coinfected with herpes simplex virus-2 (HSV-2)...
- Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant womenEdward P Acosta
University of Alabama at Birmingham, Birmingham, Alabama, USA
Antimicrob Agents Chemother 48:430-6. 2004..These PK results suggest that SQV-RTV at 800/100 mg b.i.d. appears to be a reasonable treatment option for this population...
- Changing trends in clinical AIDS presentations and survival among HIV-1-infected womenManhattan Charurat
Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland, Baltimore, MD, USA
J Womens Health (Larchmt) 13:719-30. 2004..To profile trends of clinical AIDS-defining illness (ADI) among a cohort of human immunodeficiency virus (HIV)-infected women over a 12-year period...
- Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected womenHoward Minkoff
Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Downstate, Brooklyn, New York, USA
Obstet Gynecol 108:953-60. 2006....
- Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission StudyElena L Navas-Nacher
Children s Memorial Medical Center, Chicago, Illinois, USA
AIDS 20:429-36. 2006..To assess the relationship between mode of delivery and subsequent maternal HIV-1 disease progression...
- Risk factors for in utero and intrapartum transmission of HIVLaurence S Magder
Department of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, MD, USA
J Acquir Immune Defic Syndr 38:87-95. 2005..To identify predictors of in utero and intrapartum HIV-1 transmission in infants born in the Women and Infants Transmission Study between 1990 and 2000...
- Puerto Rico Comprehensive Center for HIV DisparitiesCarmen Zorrilla; Fiscal Year: 2007..Other Core activities will be a Data Center, a Lab, a CRC, a publications office with the assistance of a writer/editor, and the recruitment of 3 health disparities investigators. ..
- University of Puerto Rico Clinical Trials UnitCarmen Zorrilla; Fiscal Year: 2007..The expertise for vaccine trials, adolescent medicine, special populations, women (pregnant and non-pregnant) and minority issues just to mention a few, can be shared between the clinical research sites. ADMINISTRATIVE COMPONENT: ..